Labay, Cristina U.
HRN: 21-12-63 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/09/2022
CLINDAMYCIN 150MG/ML, 4ML (AMP)
07/09/2022
07/16/2022
IV
600mg
Q8
Nonhealing Wound
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes